Where do we currently stand with T-cell prolymphocytic leukemia?

Amit Khot

doi:10.1080/10428194.2018.1551543

Abstract

1 min read

T-cell prolymphocytic leukemia (T-PLL), a rare mature T-cell neoplasm of older adults and a male predominance, with a post-thymic immunophenotype has generally been considered a difficult disorder ...

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2009

T-cell prolymphocytic leukemia

Amit Khot, Claire Dearden

Article2008

Alemtuzumab Administered by Subcutaneous Route Is Less Effective Than Intravenous Route for First Line Therapy of T-Cell Prolymphocytic Leukaemia: Results of a Pilot Study (UKCLL05)

Ami t S Khot, Estella Matutes, Pawel Kaczmarek, Michael R Hamblin, Ashok Roy, Effie Grand, Mark Ethell, Claire Dearden

Article2016

Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia

Ana Espírito Santo, Sérgio Chacim, Isabel Cristina Fernandes Rodrigues Ferreira, Luís Leite, Cláudia Moreira, Dulcineia Pereira, Margarida Brito, Marta C. Nunes, Nélson Domingues, Isabel Oliveira, Ilídia Moreira, Ângelo Martins, Luísa Viterbo, José Mariz, Rui Medeiros

Article1999

Class I MHC molecules on hematopoietic cells can support intrathymic positive selection of T cell receptor transgenic T cells

Jens Zerrahn, Ariane Volkmann, Mark Coles, Werner Held, François A. Lemonnier, David H Raulet

Article2006

Longitudinal Assessment of <i>de Novo</i> T Cell Production in Relation to HIV-Associated T Cell Homeostasis Failure

Pratip K. Chattopadhyay, Daniel C. Douek, Stephen J. Gange, Karen Chadwick, Marc Hellerstein, Joseph B. Margolick